In a remarkable leap for vision science, Chinese researchers have developed a revolutionary self-powered retinal implant that not only promises to restore vision in individuals with acquired blindness but could also extend human vision beyond its natural limits.
Developed by a team from Fudan University and the Chinese Academy of Sciences, the cutting-edge implant uses a network of tellurium nanowires to mimic the function of damaged photoreceptor cells in the retina. When exposed to light, it generates an electric current that activates surviving nerve cells, enabling the brain to process visual signals.
Unlike conventional visual prosthetics, this device operates without any external power source.
“This method is suitable for cases of acquired blindness,” said Wang Shuiyuan, a lead researcher at Fudan University’s College of Integrated Circuits and Micro-Nano Electronics. “It eliminates the need for external power sources, enabling minimally invasive subretinal implantation without requiring bulky auxiliary equipment.”
Implanted through a minimally invasive procedure, the tiny device — customized using laser technology — can be cut into segments as small as one-twentieth of a fingernail, tailored to the patient’s needs. Lab tests revealed that blind mice, which previously relied on smell and touch, developed light sensitivity post-implantation and could even recognize infrared-based visual patterns.
Perhaps most notably, the implant expands the visual range to include infrared wavelengths of 940 and 1,550 nanometers — significantly beyond the human range of 380 to 780 nanometers. This capability could usher in an era of “super vision,” enabling users to detect light invisible to the naked eye.
The research team also confirmed that non-human primates showed no adverse reactions even six months after surgery, highlighting the implant’s safety and long-term viability.
“This next-generation super-vision prosthesis technology could potentially push the boundaries of natural human vision limits,” Wang noted.
Future research aims to refine the precision and speed of visual signal processing, paving the way for clinical trials and, possibly, a new era of enhanced human sight.
